HLA-C and neoplasm: Loss of MHC occurs either due to homozygous deletion of MHC class II genes or chromosomal translocations in the MHC master regulator [6, 7], resulting in reduced presentation of tumor-associated antigens to host CD4+ T helper cells and therefore reduced activation of cytotoxic T lymphocytes (CTLs).